These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 9022916
21. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226. Lundberg JM, Modin A. Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732 [Abstract] [Full Text] [Related]
22. Microcirculation of the dental pulp and its autonomic control. Kim S, Dörscher-Kim JE, Liu M. Proc Finn Dent Soc; 1989 Dec; 85(4-5):279-87. PubMed ID: 2635779 [Abstract] [Full Text] [Related]
23. Sympathetic regulation of skeletal muscle blood flow in the pig: a non-adrenergic component likely to be mediated by neuropeptide Y. Modin A, Pernow J, Lundberg JM. Acta Physiol Scand; 1993 May; 148(1):1-11. PubMed ID: 8333291 [Abstract] [Full Text] [Related]
24. D-myo inositol 1,2,6, triphosphate (alpha-trinositol, pp56): selective antagonist at neuropeptide Y (NPY) Y-receptors or selective inhibitor of phosphatidylinositol cell signaling? Bell D, McDermott BJ. Gen Pharmacol; 1998 Nov; 31(5):689-96. PubMed ID: 9809464 [Abstract] [Full Text] [Related]
25. Interaction of neuropeptide Y and the sympathetic nervous system in vascular control in man. Clarke J, Benjamin N, Larkin S, Webb D, Maseri A, Davies G. Circulation; 1991 Mar; 83(3):774-7. PubMed ID: 1999028 [Abstract] [Full Text] [Related]
26. Neuropeptide Y mimics a non-adrenergic component of sympathetic vasoconstriction in the bullfrog. Stofer WD, Fatherazi S, Horn JP. J Auton Nerv Syst; 1990 Nov; 31(2):141-51. PubMed ID: 2290002 [Abstract] [Full Text] [Related]
27. Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig. Pernow J, Lundberg JM. Acta Physiol Scand; 1989 Aug; 136(4):507-17. PubMed ID: 2571235 [Abstract] [Full Text] [Related]
33. alpha-Trinositol: a functional (non-receptor) neuropeptide Y antagonist in vasculature. Sun X, You J, Hedner T, Erlinge D, Fellström B, Yoo H, Wahlestedt C, Edvinsson L. J Pharm Pharmacol; 1996 Jan; 48(1):77-84. PubMed ID: 8722501 [Abstract] [Full Text] [Related]
34. D-myo-inositol 1,2,6-trisphosphate blocks neuropeptide Y-induced facilitation of noradrenaline-evoked vasoconstriction of the mesenteric bed. Donoso MV, Boric M, Prado M, Fournier A, St Pierre S, Edvinsson L, Huidobro-Toro JP. Eur J Pharmacol; 1993 Aug 10; 240(1):93-7. PubMed ID: 8405129 [Abstract] [Full Text] [Related]
35. Neural control of pulpal blood flow. Olgart L. Crit Rev Oral Biol Med; 1996 Aug 10; 7(2):159-71. PubMed ID: 8875030 [Abstract] [Full Text] [Related]
36. Neuropeptide Y antagonism reduces reflex cutaneous vasoconstriction in humans. Stephens DP, Saad AR, Bennett LA, Kosiba WA, Johnson JM. Am J Physiol Heart Circ Physiol; 2004 Sep 10; 287(3):H1404-9. PubMed ID: 15165988 [Abstract] [Full Text] [Related]
37. Comparison of the effects of intra-arterial and locally applied vasoactive agents on pulpal blood flow in dog canine teeth determined by laser Doppler velocimetry. Liu M, Kim S, Park DS, Markowitz K, Bilotto G, Dörscher-Kim J. Arch Oral Biol; 1990 Sep 10; 35(5):405-10. PubMed ID: 2372244 [Abstract] [Full Text] [Related]
38. An in vivo and in vitro comparison of the effects of vasoactive mediators on pulpal blood vessels in rat incisors. Yu CY, Boyd NM, Cringle SJ, Su EN, Alder VA, Yu DY. Arch Oral Biol; 2002 Oct 10; 47(10):723-32. PubMed ID: 12356504 [Abstract] [Full Text] [Related]